You are here: Industry Insights > AD

News List

Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global Yi
December 20, 2024
On November 18, it was announced that VelaVigo has entered into a global strategic cooperation agreement with Avenzo Therapeutics.
Berberine: Bridging Traditional Medicine and Modern Science David Orchard-Webb
December 04, 2024
Berberine is a bioactive chemical derived from numerous plants such as Berberis species. This article dives into the therapeutic potential and historic applications of berberine.
Echinacea Extract: Therapeutic Potential and Traditional Uses David Orchard-Webb
November 05, 2024
Echinacea is known for its brilliant purple petals and cone-shaped core, has been used for generations for medicinal purposes.
What is meant by equipment upgrade? Muhammad Asim Niazi
October 21, 2024
Equipment upgrade help owners achieve higher quality products and market requirements than existing.
Application and advantages of pass-through in the Pharma industry Muhammad Asim Niazi
October 21, 2024
Transfer boxes, used in pharmaceutical manufacturing, facilitate material transfer between areas while maintaining environmental parameters.
Advancing Cryogenic Cold Chain Technology for Cell Therapy Products Saher Haider
October 15, 2024
Unlike conventional temperature-sensitive pharmaceutical products, cell therapy products have the most stringent requirements for cold chain logistics.In this article, we will dive deeper into cryogenic technology used at every step of the cold chain supp
Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization PharmaSources
October 15, 2024
Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its Supervisory Board.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part Two) Xiaomichong
July 09, 2024
In recent years, with the deepening of research into the pathogenesis of myelodysplastic syndromes (MDS), many novel drugs have emerged.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part one) Xiaomichong
July 09, 2024
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies characterized by defective normal hematopoiesis leading to a reduction in blood cells, with a risk of transformation into acute myeloid leukemia.
The Impact of Intestinal Flora on the Effective Components of Traditional Chinese Medicine Xiaomichong
July 03, 2024
The intestinal flora can produce a variety of enzymes, mainly including α-rhamnosidase, β-glucosidase, β-galactosidase, nitroreductase, 7α-hydroxylase, proteases, and multiple carbohydrate-active enzymes (CAZymes).